245 FIRST STREET, CAMBRIDGE, MA
Provides Update on Vafseo for Non-Dialysis Patients
Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Announces 2023 Stock Incentive Plan
Reports First Quarter 2025 Financial Results and Recent Business Highlights
Annual Report to Security Holders
Announces Pricing of Public Offering of Common Stock
Reports Fourth Quarter and Full Year 2024 Financial Results and Vafseo® (vadadustat) Commercial Launch Progress Update
Material disclosure
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Definitive Revised Proxy Statement
Confidential Treatment Order
Post-Effective Amendment to Registration Statement